Lowest Price Guaranteed
Pages
255
Last Updated
July 2026
View Count
29399
1. PREFACE
1.1. Cold Chain Market for Pharmaceuticals
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Introduction to Cold Chain Packaging
5.3. Historical Timeline of Cold Chain
5.4. Cold Chain Solutions for Pharmaceutical Industry
5.4.1. Cold Chain Packaging Solutions: Containers and Shippers
5.4.1.1. Active Cold Chain Packaging Solutions
5.4.1.2. Passive Cold Chain Packaging Solutions
5.4.1.3. Insulated Cold Chain Packaging Solutions
5.4.2. Cold Chain Monitoring Solutions: Data Loggers
5.4.2.1. Data Loggers
5.4.2.2. Indicators
5.5. Applications of Cold Chain in Pharmaceutical Industry
5.6. Current Challenges and Future Perspectives
6. OVERALL MARKET LANDSCAPE: COLD CHAIN CONTAINER / SHIPPER PROVIDERS
6.1. Chapter Overview
6.2. Cold Chain Container / Shipper Providers: Overall Market Landscape
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Company Size
6.2.3. Analysis by Location of Headquarters (Region)
6.2.4. Analysis by Location of Headquarters (Country)
6.2.5. Analysis by Type of Cold Chain Solution
6.2.6. Analysis by Type of Product Offered
6.2.7. Analysis by Type of Product Material
6.2.8. Analysis by Type of Product Packaged
6.2.9. Analysis by Storage Temperature
6.2.10. Analysis by Type of Service Offered
6.2.11. Analysis by Company Size and Type of Service Offered
7. OVERALL MARKET LANDSCAPE: DATA LOGGER PROVIDERS
7.1. Chapter Overview
7.2. Data Logger Providers: Overall Market Landscape
7.3. Analysis by Year of Establishment
7.4. Analysis by Company Size
7.5. Analysis by Location of Headquarters (Region)
7.6. Analysis by Location of Headquarters (Country)
7.7. Analysis by Type of Product Offered
7.8. Analysis by Mode of Data Transmission
7.9. Analysis by Type of Data Captured
7.10. Analysis by Type of Pharmaceutical Monitored
7.11. Analysis by Temperature Range
7.12. Analysis by Type of Product Offered and Mode of Data Transmission
7.13. Analysis by Type of Product Offered and Type of Data Captured
8. BENCHMARKING ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Methodology
8.3. Benchmarking Analysis of Cold Chain Container / Shipper Providers
8.3.1. Benchmarking Analysis: Players based in North America (Peer Group I)
8.3.2. Benchmarking Analysis: Players based in Europe (Peer Group II)
8.3.3. Benchmarking Analysis: Large Players based in Asia-Pacific and RoW (Peer Group III)
8.4. Concluding Remarks
9. COMPANY PROFILES
9.1. Chapter Overview
9.2. Cold Chain Technologies
9.2.1. Company Overview
9.2.2. Product Portfolio
9.2.3. Service Portfolio
9.2.4. Recent Developments and Future Outlook
9.3. Cryopak
9.3.1. Company Overview
9.3.2. Product Portfolio
9.3.3. Service Portfolio
9.3.4. Recent Developments and Future Outlook
9.4. CSafe
9.4.1. Company Overview
9.4.2. Product Portfolio
9.4.3. Service Portfolio
9.4.4. Recent Developments and Future Outlook
9.5. EMBALL'ISO
9.5.1. Company Overview
9.5.2. Product Portfolio
9.5.3. Service Portfolio
9.5.4. Recent Developments and Future Outlook
9.6. Intelsius
9.6.1. Company Overview
9.6.2. Product Portfolio
9.6.3. Service Portfolio
9.6.4. Recent Developments and Future Outlook
9.7. Nordic Cold Chain Solutions
9.7.1. Company Overview
9.7.2. Product Portfolio
9.7.3. Service Portfolio
9.7.4. Recent Developments and Future Outlook
9.8. Peli BioThermal
9.8.1. Company Overview
9.8.2. Product Portfolio
9.8.3. Service Portfolio
9.8.4. Recent Developments and Future Outlook
9.9. SEE
9.9.1. Company Overview
9.9.2. Product Portfolio
9.9.3. Service Portfolio
9.9.4. Recent Developments and Future Outlook
9.10. SOFRIGAM
9.10.1. Company Overview
9.10.2. Product Portfolio
9.10.3. Service Portfolio
9.10.4. Recent Developments and Future Outlook
9.11. Sonoco Thermosafe
9.11.1. Company Overview
9.11.2. Product Portfolio
9.11.3. Service Portfolio
9.11.4. Recent Developments and Future Outlook
9.12. Tempack
9.12.1. Company Overview
9.12.2. Product Portfolio
9.12.3. Service Portfolio
9.12.4. Recent Developments and Future Outlook
9.13. Other Leading Players
9.13.1. Almac
9.13.2. B Medical Systems
9.13.3. BioLife Solutions
9.13.4. CRS Mobile Cold Storage
9.13.5. Desert Valley Tech
9.13.6. Dubai Instruments
9.13.7. Envirotainer
9.13.8. Global Cold Chain Solutions (Headquartered in Australia)
9.13.9. Global Cold Chain Solutions (Headquartered in Singapore)
9.13.10. Klinge
9.13.11. Krautz-temax
9.13.12. Meds2go
9.13.13. phasetwo
9.13.14. Polar Tech Industries
9.13.15. Skycell
9.13.16. UPS Healthcare
10. PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Cold Chain for Pharmaceuticals: Partnerships and Collaborations
10.3.1. Analysis by Year of Partnership
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Year and Type of Partnership
10.3.4. Analysis by Application Area
10.3.5. Analysis by Type of Product / Technology Targeted
10.3.6. Analysis by Geography
10.3.6.1. Local and International Agreements
10.3.6.2. Intercontinental and Intracontinental Agreements
10.3.7. Most Active Players: Analysis by Number of Partnerships
10.4. Cold Chain for Pharmaceuticals: Acquisitions
10.4.1. Analysis by Year of Acquisition
10.4.2. Analysis by Type of Acquisition
10.4.3. Analysis by Year and Type of Acquisition
10.4.4. Analysis by Application Area
10.4.5. Analysis by Type of Product / Technology Targeted
10.4.6. Analysis by Geography
10.4.6.1. Local and International Agreements
10.4.6.2. Intercontinental and Intracontinental Agreements
10.4.7. Ownership Change Matrix
10.4.8. Analysis by Key Value Drivers
11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Cold Chain for Pharmaceuticals: Patent Analysis
11.3.1. Analysis by Type of Patent
11.3.2. Analysis by Publication Year
11.3.3. Analysis by Type of Patent and Publication Year
11.3.4. Analysis by Application Year
11.3.5. Analysis by Type of Organization
11.3.6. Analysis by Patent Jurisdiction
11.3.7. Analysis by CPC Symbols
11.3.8. Analysis by Emerging Focus Area
11.3.9. Leading Industry Players: Analysis by Number of Patents
11.4. Cold Chain for Pharmaceuticals: Patent Benchmarking Analysis
11.4.1. Analysis by Patent Characteristics
11.4.1.1. Cold Chain Technologies and Ember LifeSciences
11.4.1.2. Other Leading Patent Assignees
11.5. Patent Valuation Analysis
12. REGULATORY RECOMMENDATIONS AND GUIDELINES
12.1. Chapter Overview
12.2. Regulatory Guidelines Issued by International Authorities
12.2.1. World Health Organization (WHO)
12.2.2. International Air Transport Association (IATA)
12.2.3. International Safe Transit Association (ISTA)
12.3. Regulatory Guidelines Issued by Regional Authorities
12.3.1. Regulatory Guidelines for Cold Chain Management in the US
12.3.1.1. United States Food and Drug Administration (USFDA)
12.3.2. United States Pharmacopeia (USP)
12.3.3. Regulatory Guidelines for Cold Chain Management in Canada
12.3.3.1. Health Canada
12.3.4. Regulatory Guidelines for Cold Chain Management in Europe
12.3.4.1. European Medicine Agency
12.4. Recommendations for Different Steps of Cold Chain
12.5. Comparative Analysis of Regulatory Authorities
13.UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES
13.1. Chapter Overview
13.2. Connected Cold Chain: Key Tools and Technologies
13.2.1. Artificial Intelligence
13.2.2. Augmented Reality
13.2.3. Automation and Robotics
13.2.4. Big Data Analytics
13.2.5. Block Chain Technology
13.2.6. Cloud Computing
13.2.7. Internet of Things
13.2.8. Radio Frequency Identification (RFID) Tags
13.3. Connected Cold Chain: Future Growth Opportunities
13.4. Real-Time Monitoring: An Application of Connected Cold Chain Solutions
13.4.1. Methods for Integration of Real-Time Monitoring in Cold Chain
13.4.1.1. RFID Based Real-Time Monitoring
13.4.1.2. Blockchain And IoT Based Real-Time Monitorin
13.4.2. Growth Opportunities for Real-Time Monitoring in Connected Cold Chain
13.4.3. Cost Benefits of Real-Time Monitoring in Cold Chain
14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
14.1. Chapter Overview
14.2. Market Drivers
14.3. Market Restraints
14.4. Market Opportunities
14.5. Market Challenges
14.6. Conclusion
15. COLD CHAIN MARKET FOR PHARMACEUTICALS
15.1. Chapter Overview
15.2. Assumptions and Methodology
15.3. Global Cold Chain Market for Pharmaceuticals, Historical Trends (since 2019) and Forecasted Estimates (till 2035)
15.3.1. Scenario Analysis
15.4. Key Market Segmentations
15.5. Dynamic Dashboard
16. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF PRIMARY PACKAGING
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Cold Chain for Pharmaceuticals: Analysis by Type of Primary Packaging (2019, current year and 2035)
16.3.1. Vials: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
16.3.2. Ampoules: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
16.3.3. Pre-filled Syringes: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
16.3.4. Bags: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
16.4. Data Triangulation and Validation
17. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF SECONDARY PACKAGING
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Cold Chain for Pharmaceuticals: Analysis by Type of Secondary Packaging (2019, current year and 2035)
17.3.1. Cold Boxes: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
17.3.2. Vaccine Carriers: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
17.3.3. Insulated Containers: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
17.4. Data Triangulation and Validation
18. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF USABILITY
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Cold Chain for Pharmaceuticals: Analysis by Type of Usability (2019, current year and 2035)
18.3.1. Reusable Containers / Shippers: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
18.3.2. Single-use Containers / Shippers: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
18.4. Data Triangulation and Validation
19. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY KEY GEOGRAPHICAL REGIONS
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Cold Chain for Pharmaceuticals: Analysis by Key Geographical Regions (2019, current year and 2035)
19.3.1. North America: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
19.3.2. Europe: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
19.3.3. Asia-Pacific: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
19.3.4. Middle East and North America: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
19.3.5. Latin America: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
19.3.6. Rest of the World: Historical Trends (since 2019) and Forecasted Estimates (till 2035)
19.4. Data Triangulation and Validation
20. CONCLUSION
21. EXECUTIVE INSIGHTS
21.1. Chapter Overview
21.2. EMBALL’ISO
21.2.1. Company Snapshot
21.2.2. Interview Transcript
21.3. Tower Cold Chain
21.3.1. Company Snapshot
21.3.2. Interview Transcript
22. APPENDIX 1: TABULATED DATA
23. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
Figure 4.1 Executive Summary: Overall Market Landscape of Cold Chain Container / Shipper Providers
Figure 4.2 Executive Summary: Overall Market Landscape of Data Logger Providers
Figure 4.3 Executive Summary: Benchmarking Analysis
Figure 4.4 Executive Summary: Partnerships and Collaborations
Figure 4.5 Executive Summary: Mergers and Acquisitions
Figure 4.6 Executive Summary: Patent Analysis
Figure 4.7 Executive Summary: Market Forecast and Opportunity Analysis
Figure 5.1 Elements of Cold Chain Packaging
Figure 5.2 Historical Timeline of Cold Chain
Figure 5.3 Types of Active Cold Chain Refrigerators / Freezers
Figure 5.4 Types of Material used in Passive Cold Chain Containers
Figure 5.5 Types of Insulated Cold Chain Containers
Figure 5.6 Applications of Cold Chain in Pharmaceutical Industry
Figure 6.1 Cold Chain Container / Shipper Providers: Distribution by Year of Establishment
Figure 6.2 Cold Chain Container / Shipper Providers: Distribution by Company Size
Figure 6.3 Cold Chain Container / Shipper Providers: Distribution by Location of Headquarters (Region)
Figure 6.4 Cold Chain Container / Shipper Providers: Distribution by Location of Headquarters (Country)
Figure 6.5 Cold Chain Container / Shipper Providers: Distribution by Type of Cold Chain Solution
Figure 6.6 Cold Chain Container / Shipper Providers: Distribution by Type of Product Offered
Figure 6.7 Cold Chain Container / Shipper Providers: Distribution by Type of Product Material
Figure 6.8 Cold Chain Container / Shipper Providers: Distribution by Type of Product Packaged
Figure 6.9 Cold Chain Container / Shipper Providers: Distribution by Storage Temperature
Figure 6.10 Cold Chain Container / Shipper Providers: Distribution by Type of Service Offered
Figure 6.11 Cold Chain Container / Shipper Providers: Distribution by Company Size and Type of Service Offered
Figure 7.1 Cold Chain Data Logger Providers: Distribution by Year of Establishment
Figure 7.2 Cold Chain Data Logger Providers: Distribution by Company Size
Figure 7.3 Cold Chain Data Logger Providers: Distribution by Location of Headquarters (Region)
Figure 7.4 Cold Chain Data Logger Providers: Distribution by Location of Headquarters (Country)
Figure 7.5 Cold Chain Data Logger Providers: Distribution by Type of Product Offered
Figure 7.6 Cold Chain Data Logger Providers: Distribution by Mode of Data Transmission
Figure 7.7 Cold Chain Data Logger Providers: Distribution by Type of Data Captured
Figure 7.8 Cold Chain Data Logger Providers: Distribution by Type of Pharmaceutical Monitored
Figure 7.9 Cold Chain Data Logger Providers: Distribution by Temperature Range
Figure 7.10 Cold Chain Data Logger Providers: Distribution by Type of Product Offered and Mode of Data Transmission
Figure 7.11 Cold Chain Data Logger Providers: Distribution by Type of Product Offered and Type of Data Captured
Figure 8.1 Benchmarking Analysis: Players based in North America (Peer Group I)
Figure 8.2 Benchmarking Analysis: Players based in Europe (Peer Group II)
Figure 8.3 Benchmarking Analysis: Players based in Asia-Pacific and RoW (Peer Group III)
Figure 9.1 Cold Chain Technologies: Product Portfolio
Figure 9.2 Cold Chain Technologies: Cold Chain Packaging Service Portfolio
Figure 9.3 Cryopak: Product Portfolio
Figure 9.4 Cryopak: Cold Chain Packaging Service Portfolio
Figure 9.5 CSafe: Product Portfolio
Figure 9.6 CSafe: Cold Chain Packaging Service Portfolio
Figure 9.7 EMBALL’ISO: Product Portfolio
Figure 9.8 EMBALL’ISO: Cold Chain Packaging Service Portfolio
Figure 9.9 Intelsius: Product Portfolio
Figure 9.10 Intelsius: Cold Chain Packaging Service Portfolio
Figure 9.11 Nordic Cold Chain Solutions: Product Portfolio
Figure 9.12 Nordic Cold Chain Solutions: Cold Chain Packaging Service Portfolio
Figure 9.13 Peli BioThermal: Product Portfolio
Figure 9.14 Peli BioThermal: Cold Chain Packaging Service Portfolio
Figure 9.15 SEE: Product Portfolio
Figure 9.16 SEE: Cold Chain Packaging Service Portfolio
Figure 9.17 SOFRIGAM: Product Portfolio
Figure 9.18 SOFRIGAM: Cold Chain Packaging Service Portfolio
Figure 9.19 Sonoco Thermosafe: Product Portfolio
Figure 9.20 Sonoco Thermosafe: Cold Chain Packaging Service Portfolio
Figure 9.21 Tempack: Product Portfolio
Figure 9.22 Tempack: Cold Chain Packaging Service Portfolio
Figure 10.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 10.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 10.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 10.4 Partnerships and Collaborations: Distribution by Application Area
Figure 10.5 Partnerships and Collaborations: Distribution by Type of Product
Figure 10.6 Partnerships and Collaborations: Local and International Agreements
Figure 10.7 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.8 Most Active Players: Distribution by Number of Partnerships
Figure 10.9 Acquisitions: Distribution by Year of Acquisition
Figure 10.10 Acquisitions: Distribution by Type of Acquisition
Figure 10.11 Acquisitions: Distribution by Year and Type of Acquisition
Figure 10.12 Acquisitions: Distribution by Application Area
Figure 10.13 Acquisitions: Distribution by Type of Product
Figure 10.14 Acquisitions: Local and International Agreements
Figure 10.15 Acquisitions: Intercontinental and Intracontinental Agreements
Figure 10.16 Most Active Players: Distribution by Number of Acquisitions
Figure 10.17 Acquisitions: Ownership Change Matrix
Figure 10.18 Acquisitions: Distribution by Key Value Drivers
Figure 11.1 Patent Analysis: Distribution by Type of Patent
Figure 11.2 Patent Analysis: Distribution by Publication Year
Figure 11.3 Patent Analysis: Distribution by Type of Patent and Publication Year
Figure 11.4 Patent Analysis: Distribution by CPC Symbols
Figure 11.5 Patent Analysis: Distribution by Type of Organization
Figure 11.6 Patent Analysis: Distribution by Patent Jurisdiction
Figure 11.7 Word Cloud: Emerging Focus Areas
Figure 11.8 Patent Analysis: Distribution by Application Year
Figure 11.9 Leading Industry Players: Distribution by Number of Patents
Figure 11.10 Patent Analysis (Cold Chain Technologies and Ember LifeSciences): Benchmarking by PatentCharacteristics
Figure 11.11 Patent Analysis (Other Leading Patent Assignees): Benchmarking by Patent Characteristics
Figure 11.12 Patent Analysis: Distribution by Patent Age
Figure 11.13 Patent Analysis: Categorizations based on Weighted Valuation Scores
Figure 11.14 Cold Chain Market for Pharmaceuticals: Patent Valuation Analysis
Figure 12.1 Cold Chain in Pharmaceuticals: International and Regional Regulatory Authorities
Figure 12.2 WHO Guidelines for Cold Chain Management
Figure 12.3 IATA (CEIV Pharma) Guidelines for Cold Chain Management
Figure 12.4 ISTA Guidelines for Cold Chain Management
Figure 12.5 USFDA Guidelines for Cold Chain
Figure 12.6 USFDA Form483s Excerpts: Challenges and Solutions Related to Cold Chain
Figure 12.7 USP Guidelines for Cold Chain
Figure 12.8 EMA Guidelines for Cold Chain
Figure 12.9 Regulatory Requirements for Various Steps of Cold Chain
Figure 12.10 Comparative Analysis of Regulatory Authorities
Figure 13.1 Connected Cold Chain: Process Flow Model
Figure 13.2 Artificial Intelligence in Cold Chain: Key Benefits and Challenges
Figure 13.3 Augmented Reality in Cold Chain: Key Benefits and Challenges
Figure 13.4 Automation and Robotics in Cold Chain: Key Benefits and Challenges
Figure 13.5 Big Data Analytics in Cold Chain: Key Benefits and Challenges
Figure 13.6 Blockchain Technology in Cold Chain: Key Benefits and Challenges
Figure 13.7 Cloud Computing in Cold Chain: Key Benefits and Challenges
Figure 13.8 Internet of Things in Cold Chain: Schematic Representation
Figure 13.9 Internet of Things in Cold Chain Logistics: Key Benefits and Challenges
Figure 13.10 RFID Tags in Cold Chain Logistics: Key Benefits and Challenges
Figure 13.11 Connected Cold Chain: Future Growth Opportunities (Harvey Ball Analysis)
Figure 13.12 Real-Time Monitoring: Conventional Devices
Figure 13.13 RFID Based Real-Time Monitoring in Cold Chain
Figure 13.14 Key Contributions of Blockchain Technology and IoT in Real-Time Monitoring
Figure 13.15 Blockchain Technology and IoT Based Real-Time Monitoring: Flow Diagram
Figure 13.16 Real-Time Monitoring in Cold Chain Management: Growth Opportunities
Figure 13.17 Real-Time Monitoring: Reduction in Cold Chain Cost
Figure 15.1 Global Cold Chain Market for Pharmaceuticals, Historical Trends (2019-2022)
Figure 15.2 Global Cold Chain Market for Pharmaceuticals, Forecasted Estimates (2023-2035), Base Scenario (USD Million)
Figure 15.3 Global Cold Chain Market for Pharmaceuticals, Forecasted Estimates (2023-2035), Conservative Scenario (USD Billion)
Figure 15.4 Global Cold Chain Market for Pharmaceuticals, Forecasted Estimates (2023-2035), Optimistic Scenario (USD Billion)
Figure 16.1 Global Cold Chain Market for Pharmaceuticals: Distribution by Type of Primary Packaging, 2019, 2023 and 2035 (USD Billion)
Figure 16.2 Cold Chain Market for Vials, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 16.3 Cold Chain Market for Ampoules, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 16.4 Cold Chain Market for Pre-filled Syringes, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 16.5 Cold Chain Market for Bags, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 17.1 Global Cold Chain Market for Pharmaceuticals: Distribution by Type of Secondary Packaging, 2019, 2023 and 2035 (USD Billion)
Figure 17.2 Cold Chain Market for Cold Boxes, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 17.3 Cold Chain Market for Vaccine Carriers, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 17.4 Cold Chain Market for Insulated Containers, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 18.1 Global Cold Chain Market for Pharmaceuticals: Distribution by Type of Usability, 2019, 2023 and 2035 (USD Billion)
Figure 18.2 Cold Chain Market for Reusable Containers / Shipper, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 18.3 Cold Chain Market for Single-use Containers / Shippers, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 19.1 Global Cold Chain Market for Pharmaceuticals: Distribution by Key Geographical Regions, 2019, 2023 and 2035 (USD Billion)
Figure 19.2 Cold Chain Market for Pharmaceuticals in North America, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 19.3 Cold Chain Market for Pharmaceuticals in Europe, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 19.4 Cold Chain Market for Pharmaceuticals in Asia-Pacific, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 19.5 Cold Chain Market for Pharmaceuticals in Middle East and North Africa, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 19.6 Cold Chain Market for Pharmaceuticals in Latin America, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 19.7 Cold Chain Market for Pharmaceuticals in Rest of the World, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 20.1 Concluding Remarks: Overall Market Landscape of Cold Chain Container / Shipper Providers
Figure 20.2 Concluding Remarks: Overall Market Landscape of Data Logger Providers
Figure 20.3 Concluding Remarks: Benchmarking Analysis
Figure 20.4 Concluding Remarks: Partnerships and Collaborations
Figure 20.5 Concluding Remarks: Mergers and Acquisitions
Figure 20.6 Concluding Remarks: Patent Analysis
Figure 20.7 Concluding Remarks: Market Forecast and Opportunity Analysis
Table 6.1 Cold Chain Container / Shipper Providers: List of Companies
Table 6.2 Cold Chain Container / Shipper Providers: Information on Product Material
Table 6.3 Cold Chain Container / Shipper Providers: Information on Type of Product Packaged
Table 6.4 Cold Chain Container / Shipper Providers: Information on Storage Temperature and Type of Service Offered
Table 7.1 Cold Chain Data Logger Providers: List of Companies
Table 7.2 Cold Chain Data Logger Providers: Information on Type of Data Captured
Table 7.3 Cold Chain Data Logger Providers: Information on Type of Pharmaceutical Monitored
Table 7.4 Cold Chain Data Logger Providers: Information on Temperature Range
Table 8.1 Benchmarking Analysis: Peer Groups Definitions and Inclusions
Table 9.1 Cold Chain for Pharmaceuticals: List of Companies Profiled
Table 9.2 Cold Chain for Pharmaceuticals: Other Leading Players Profiled
Table 9.3 Cold Chain Technologies: Company Overview
Table 9.4 Cold Chain Technologies: Recent Developments and Future Outlook
Table 9.5 Cryopak: Company Overview
Table 9.6 Cyropak: Recent Developments and Future Outlook
Table 9.7 CSafe: Company Overview
Table 9.8 CSafe: Recent Developments and Future Outlook
Table 9.9 EMBALL’ISO: Company Overview
Table 9.10 EMBALL’ISO: Recent Developments and Future Outlook
Table 9.11 Intelsius: Company Overview
Table 9.12 Intelsius: Recent Developments and Future Outlook
Table 9.13 Nordic Cold Chain Solutions: Company Overview
Table 9.14 Peli BioThermal: Company Overview
Table 9.15 Peli BioThermal: Recent Developments and Future Outlook
Table 9.16 SEE: Company Overview
Table 9.17 SEE: Recent Developments and Future Outlook
Table 9.18 SOFRIGAM: Company Overview
Table 9.19 SOFRIGAM: Recent Developments and Future Outlook
Table 9.20 Sonoco Thermosafe: Company Overview
Table 9.21 Sonoco Thermosafe: Recent Developments and Future Outlook
Table 9.22 Tempack: Company Overview
Table 9.23 Almac: Company Overview
Table 9.24 B Medical Systems: Company Overview
Table 9.25 BioLife Solutions: Company Overview
Table 9.26 CRS Mobile Cold Storage: Company Overview
Table 9.27 Desert Valley Tech: Company Overview
Table 9.28 Dubai Instruments: Company Overview
Table 9.29 Envirotainer: Company Overview
Table 9.30 Global Cold Chain Solutions (Headquartered in Australia): Company Overview
Table 9.31 Global Cold Chain Solutions (Headquartered in Singapore): Company Overview
Table 9.32 Klinge: Company Overview
Table 9.33 Krautz-temax: Company Overview
Table 9.34 Meds2go: Company Overview
Table 9.35 phasetwo: Company Overview
Table 9.36 Polar Tech Industries: Company Overview
Table 9.37 Skycell: Company Overview
Table 9.38 UPS Healthcare: Company Overview
Table 10.1 Cold Chain for Pharmaceuticals: List of Partnerships and Collaborations, 2019-2023
Table 10.2 Partnerships and Collaborations: Information on Application Area and Type of Product
Table 10.3 Cold Chain for Pharmaceuticals: List of Acquisitions, 2019-2023
Table 10.4 Acquisitions: Information on Application Area and Type of Product
Table 10.5 Acquisitions: Information on Key Value Drivers
Table 11.1 Patent Analysis: Top CPC Sections
Table 11.2 Patent Analysis: Most Popular CPC Symbols
Table 11.3 Patent Analysis: Top Ten CPC Symbols
Table 11.4 Patent Analysis: Summary of Benchmarking Analysis
Table 11.5 Patent Analysis: List of Leading Patents (by Highest Relative Valuation)
Table 13.1 Artificial Intelligence in Cold Chain: List of Companies
Table 13.2 Automation and Robotics in Cold Chain: List of Companies
Table 13.3 Big Data Analytics in Cold Chain: List of Companies
Table 13.4 Blockchain Technology in Cold Chain: List of Companies
Table 13.5 Cloud Computing in Cold Chain: List of Companies
Table 13.6 Internet of Things in Cold Chain: List of Companies
Table 13.7 RFID Tags in Cold Chain: List of Companies
Table 22.1 Cold Chain Container / Shipper Providers: Distribution by Year of Establishment
Table 22.2 Cold Chain Container / Shipper Providers: Distribution by Company Size
Table 22.3 Cold Chain Container / Shipper Providers: Distribution by Location of Headquarters (Region)
Table 22.4 Cold Chain Container / Shipper Providers: Distribution by Location of Headquarters (Country)
Table 22.5 Cold Chain Container / Shipper Providers: Distribution by Type of Cold Chain Solution
Table 22.6 Cold Chain Container / Shipper Providers: Distribution by Type of Product Offered
Table 22.7 Cold Chain Container / Shipper Providers: Distribution by Type of Product Material
Table 22.8 Cold Chain Container / Shipper Providers: Distribution by Type of Product Packaged
Table 22.9 Cold Chain Container / Shipper Providers: Distribution by Storage Temperature
Table 22.10 Cold Chain Container / Shipper Providers: Distribution by Type of Service Offered
Table 22.11 Cold Chain Container / Shipper Providers: Distribution by Company Size and Type of Service Offered
Table 22.12 Cold Chain Data Logger Providers: Distribution by Year of Establishment
Table 22.13 Cold Chain Data Logger Providers: Distribution by Company Size
Table 22.14 Cold Chain Data Logger Providers: Distribution by Location of Headquarters (Region)
Table 22.15 Cold Chain Data Logger Providers: Distribution by Location of Headquarters (Country)
Table 22.16 Cold Chain Data Logger Providers: Distribution by Type of Product Offered
Table 22.17 Cold Chain Data Logger Providers: Distribution by Mode of Data Transmission
Table 22.18 Cold Chain Data Logger Providers: Distribution by Type of Data Captured
Table 22.19 Cold Chain Data Logger Providers: Distribution by Type of Pharmaceutical Monitored
Table 22.20 Cold Chain Data Logger Providers: Distribution by Temperature Range
Table 22.21 Cold Chain Data Logger Providers: Distribution by Type of Product Offered and Mode of Data Transmission
Table 22.22 Cold Chain Data Logger Providers: Distribution by Type of Product Offered and Type of Data Captured
Table 22.23 Partnerships and Collaborations: Distribution by Year of Partnership
Table 22.24 Partnerships and Collaborations: Distribution by Type of Partnership
Table 22.25 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 22.26 Partnerships and Collaborations: Distribution by Application Area
Table 22.27 Partnerships and Collaborations: Distribution by Year and Application Area of the Partnership
Table 22.28 Partnerships and Collaborations: Distribution by Type of Product
Table 22.29 Partnerships and Collaborations: Local and International Agreements
Table 22.30 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 22.31 Most Active Players: Distribution by Number of Partnerships
Table 22.32 Acquisitions: Distribution by Year of Acquisition
Table 22.33 Acquisitions: Distribution by Type of Acquisition
Table 22.34 Acquisitions: Distribution by Year and Type of Acquisition
Table 22.35 Acquisitions: Distribution by Application Area
Table 22.36 Acquisitions: Distribution by Type of Product
Table 22.37 Acquisitions: Local and International Agreements
Table 22.38 Acquisitions: Intercontinental and Intracontinental Agreements
Table 22.39 Acquisitions: Ownership Change Matrix
Table 22.40 Acquisitions: Distribution by Key Value Drivers
Table 22.41 Patent Analysis: Distribution by Type of Patent
Table 22.42 Patent Analysis: Distribution by Publication Year
Table 22.43 Patent Analysis: Distribution by Type of Patent and Publication Year
Table 22.44 Patent Analysis: Distribution by Type of Organization
Table 22.45 Patent Analysis: Distribution by Patent Jurisdiction
Table 22.46 Patent Analysis: Distribution by Application Year
Table 22.47 Leading Industry Players: Distribution by Number of Patents
Table 22.48 Patent Analysis: Distribution by Patent Age
Table 22.49 Cold Chain Market for Pharmaceuticals: Patent Valuation Analysis
Table 22.50 Global Cold Chain Market for Pharmaceuticals, Historical Trends (2019-2022)
Table 22.51 Global Cold Chain Market for Pharmaceuticals, Forecasted Estimates (2023-2035), Base Scenario (USD Billion)
Table 22.52 Global Cold Chain Market for Pharmaceuticals, Forecasted Estimates (2023-2035), Conservative Scenario (USD Billion)
Table 22.53 Global Cold Chain Market for Pharmaceuticals, Forecasted Estimates (2023-2035), Optimistic Scenario (USD Billion)
Table 22.54 Global Cold Chain Market for Pharmaceuticals: Distribution by Type of Primary Packaging, 2019, 2023 and 2035 (USD Billion)
Table 22.55 Cold Chain Market for Vials, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Table 22.56 Cold Chain Market for Ampoules, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Table 22.57 Cold Chain Market for Pre-filled Syringes, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Table 22.58 Cold Chain Market for Bags, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Table 22.59 Global Cold Chain Market for Pharmaceuticals: Distribution by Type of Secondary Packaging, 2019, 2023 and 2035 (USD Billion)
Table 22.60 Cold Chain Market for Cold Boxes, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Table 22.61 Cold Chain Market for Vaccine Carriers, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Table 22.62 Cold Chain Market for Insulated Containers, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Table 22.63 Global Cold Chain Market for Pharmaceuticals: Distribution by Type of Usability, 2019, 2023 and 2035 (USD Billion)
Table 22.64 Cold Chain Market for Reusable Containers / Shipper, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Table 22.65 Cold Chain Market for Single-use Containers / Shippers, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Table 22.66 Global Cold Chain Market for Pharmaceuticals: Distribution by Key Geographical Regions, 2019, 2023 and 2035 (USD Billion)
Table 22.67 Cold Chain Market for Pharmaceuticals in North America, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Table 22.68 Cold Chain Market for Pharmaceuticals in Europe, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Table 22.69 Cold Chain Market for Pharmaceuticals in Asia-Pacific, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Table 22.70 Cold Chain Market for Pharmaceuticals in Middle East and North Africa, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)(USD Billion)
Table 22.71 Cold Chain Market for Pharmaceuticals in Latin America, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Table 22.72 Cold Chain Market for Pharmaceuticals in Rest of the World, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Please reach out to our team for the details.